NCT00056277 - Bipolar Disorder Study for Men and Women | Biotech Hunter

Enrollment

150

Participants

Timeline

Start Date

February 27, 2003

Primary Completion Date

August 1, 2005

Study Completion Date

December 14, 2005

Conditions

Bipolar Disorder

Interventions

DRUG

lamotrigine

Trial Locations (20)

10021

GSK Investigational Site, New York

10570

GSK Investigational Site, Pleasantville

27609

GSK Investigational Site, Raleigh

29201

GSK Investigational Site, Columbia

30060

GSK Investigational Site, Marietta

44106

GSK Investigational Site, Cleveland

44141

GSK Investigational Site, Brecksville

45242

GSK Investigational Site, Cincinnati

47802

GSK Investigational Site, Terre Haute

53223

GSK Investigational Site, Brown Deer

63301

GSK Investigational Site, Saint Charles

71101

GSK Investigational Site, Shreveport

77090

GSK Investigational Site, San Antonio

90210

GSK Investigational Site, Beverly Hills

92093

GSK Investigational Site, La Jolla

92108

GSK Investigational Site, San Diego

92705

GSK Investigational Site, Santa Ana

97210

GSK Investigational Site, Portland

97401

GSK Investigational Site, Eugene

08540

GSK Investigational Site, Princeton